Notice for budesonide (Dr Falk Pharma Australia Pty Ltd)
Active ingredients
budesonide
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Orodispersible tablet
Indication
For the treatment of eosinophilic oesophagitis (EoE)
Therapeutic area
Gastroenterology